tiprankstipranks
Trending News
More News >
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Income Statement

Compare
17,824 Followers

Moderna Income Statement

Last quarter (Q3 2025), Moderna's total revenue was $1.02B, a decrease of -45.23% from the same quarter last year. In Q3, Moderna's net income was $-200.00M. See Moderna’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.20B$ 6.85B$ 18.88B$ 17.74B$ 803.39M
Gross Profit
$ 1.74B$ 2.15B$ 13.46B$ 15.12B$ 764.21M
Operating Expenses
$ 5.68B$ 6.39B$ 4.04B$ 1.82B$ 1.53B
Depreciation and Amortization
$ 189.00M$ 621.00M$ 348.00M$ 232.00M$ 31.25M
EBITDA
$ -3.39B$ -3.28B$ 9.77B$ 13.53B$ -703.38M
Operating Income
$ -3.94B$ -4.24B$ 9.42B$ 13.30B$ -763.14M
Other Income/Expenses
$ 338.00M$ 297.00M$ 155.00M$ -11.00M$ 18.63M
Pretax Income
$ -3.61B$ -3.94B$ 9.57B$ 13.29B$ -744.51M
Net Income
$ -3.56B$ -4.71B$ 8.36B$ 12.20B$ -747.06M
Per Share Metrics
Basic EPS
$ -9.27$ -12.34$ 21.26$ 30.31$ -1.96
Diluted EPS
$ -9.27$ -12.34$ 20.10$ 28.29$ -1.96
Weighted Average Shares Outstanding
384.00M 382.00M 394.00M 403.00M 381.33M
Weighted Average Shares Outstanding (Diluted)
384.00M 382.00M 416.00M 431.00M 381.33M
Currency in USD

Moderna Earnings and Revenue History